Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants

Martin M. Katz, Uriel M. Halbreich, Charles L. Bowden, Alan Frazer, Roger M. Pinder, A. John Rush, David P. Wheatley, Barry D. Lebowitz

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science